BPDO-1603

· Hyundai Pharmaceutical Co., LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BPDO-1603, covering 2020-04-22 to 2020-04-22. Get the full timeline:

Most recent: Clinical Trial Update: BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease [Phase 3]